Alexion AstraZeneca Rare Disease is a global biopharmaceutical company that is dedicated to developing life-changing therapies for individuals who are living with rare disorders. With a focus on rare diseases, Alexion AstraZeneca Rare Disease works towards providing innovative solutions and treatments.

Nordic Rare Disease Summit 2023 is organised and financed by Takeda Pharma with contributions from Alexion AstraZeneca Rare Disease, Novo Nordisk and Sobi.

announced today the completion of our acquisition, marking the creation of “Alexion, AstraZeneca Rare Disease.” Read more: https://bit.ly/ ...

LogicBio has been acquired by Alexion, AstraZeneca Rare Disease. For ... Alexion, AstraZeneca Rare Disease to Acquire LogicBio® Therapeutics ...

Alexion AstraZeneca Rare Disease

Find contacts at this company